Deep Track Capital, LP Pliant Therapeutics, Inc. Transaction History
Deep Track Capital, LP
- $2.86 Billion
- Q1 2025
A detailed history of Deep Track Capital, LP transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 5,399,681 shares of PLRX stock, worth $8.86 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
5,399,681
Previous 5,972,257
9.59%
Holding current value
$8.86 Million
Previous $78.7 Million
90.73%
% of portfolio
0.25%
Previous 3.46%
Shares
8 transactions
Others Institutions Holding PLRX
# of Institutions
154Shares Held
62.2MCall Options Held
279KPut Options Held
7.1K-
Tang Capital Management LLC San Diego, CA6MShares$9.84 Million0.53% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$8.15 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$5.47 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.05MShares$5 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.01MShares$4.94 Million25.76% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $79.8M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...